Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4536932 | 0.81 | DRD2 (0.65) | DRD2DRD3 | |
| SCHEMBL357358 | 0.81 | DRD2 (0.65) | DRD2DRD3 | |
| SCHEMBL1626963 | 0.81 | DRD2 (0.65) | DRD2DRD3 | |
| SCHEMBL8538844 | 0.81 | DRD2 (0.65) | DRD2DRD3 | |
| SCHEMBL25173291 | 0.81 | DRD2 (0.49) | DRD2DRD3 | |
| Water SCHEMBL27733441 | 0.80 | DRD2 (0.51) | DRD2DRD3 | |
| SCHEMBL30404065 | 0.80 | DRD2 (0.55) | DRD2DRD3 | |
| SCHEMBL2564441 | 0.80 | DRD2 (0.55) | DRD2DRD3 | |
| SCHEMBL503067 | 0.79 | DRD2 (0.54) | DRD2DRD3 | |
| SCHEMBL188447 | 0.79 | DRD2 (0.54) | DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119080791-A | Construction of 1, 3-dioxolane derivatives by catalyzing electron-deficient alkenyl ethylene oxide through Lewis base | 山东第一医科大学(山东省医学科学院) | 2024-12-06 | — | — | CN | claimed |
| WO-2023225776-A1 | METHOD FOR PREPARING HIGHLY SENSITIVE AND STABLE CHEMILUMINESCENT SUBSTRATE LIQUID AND USE THEREOF IN IMMUNOASSAY | 孙嘉怡 | 2023-11-30 | — | — | WO | claimed |
| CN-112608355-A | Preparation method of tetraacetylglucose | 北京悦康科创医药科技股份有限公司 | 2021-04-06 | — | — | CN | claimed |
| CN-109553591-B | Preparation method of quetiapine fumarate intermediate | 山东安信制药有限公司 | 2020-12-15 | — | — | CN | claimed |
| CN-111757901-A | Process for preparing compositions comprising polyurethanes with NCO end groups | 博斯蒂克股份公司 | 2020-10-09 | — | — | CN | claimed |
| CN-111303209-A | Preparation method of degradation impurity of prophenoltenofovir | 石家庄龙泽制药股份有限公司 | 2020-06-19 | — | — | CN | claimed |
| CN-101970397-B | Process for preparing 2-amino-5-cyanobenzoic acid derivatives | DU PONT | 2014-04-16 | — | — | CN | claimed |
| CN-101970397-A | Process for preparing 2-amino-5-cyanobenzoic acid derivatives | DU PONT | 2011-02-09 | — | — | CN | claimed |
| CN-100467471-C | Method for producing zopiclone | QILU TIANHE HUISHI PHARMACY CO (CN) | 2009-03-11 | — | — | CN | claimed |
| CN-101195624-A | Method for preparing zopiclone | QILU TIANHE HUISHI PHARMACY CO (CN) | 2008-06-11 | — | — | CN | claimed |
| EP-0138153-B1 | A SELECTIVE ACYLATION PROCESS | AB LEO (SE) | 1988-11-23 | — | — | EP | claimed |
| US-4592869-A | Selective acylation process | AKTIEBOLAGET LEO (SE) | 1986-06-03 | — | — | US | claimed |
| EP-0138153-A2 | A selective acylation process | AB LEO (SE) | 1985-04-24 | — | — | EP | claimed |
| EP-4739682-A1 | 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS | Janssen Pharmaceutica NV (BE) | 2026-05-13 | — | — | EP | disclosed |
| WO-2026088070-A1 | COMPOUNDS | PFIZER INC. (US) | 2026-04-30 | — | — | WO | disclosed |
| EP-4146220-B1 | HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE | AMGEN INC (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-0483479-B1 | Pyridiniumsalts containing alkoxysilyl groups | HUELS CHEMISCHE WERKE AG (DE) | 1995-03-08 | — | — | EP | disclosed |
| US-5371216-A | Pyridinium salts containing alkoxysilyl groups | HULS AKTIENGESELLSCHAFT (DE) | 1994-12-06 | — | — | US | disclosed |
| US-5235051-A | PYRIDINIUM SALTS CONTAINING ALKOXYSILYL GROUPS | HULS AKTIENGESELLSCHAFT (DE) | 1993-08-10 | — | — | US | disclosed |
| EP-0483479-A1 | Pyridiniumsalts containing alkoxysilyl groups | HÜLS AKTIENGESELLSCHAFT (DE) | 1992-05-06 | — | — | EP | disclosed |